Witzelsucht
Witzelsucht is a rare neurological disorder characterized by a tendency to make puns, or tell inappropriate jokes or pointless stories in socially inappropriate situations. It makes one unable to resist telling jokes and stories. The patient nevertheless finds these utterances intensely amusing. It is associated with small lesions of the orbitofrontal cortex. It is distinguished from pathological laughing by virtue of congruent affect and cognition. It is most commonly seen in patients with frontal lobe damage, particularly right frontal lobe tumors or trauma.
Symptoms[edit]
The main symptom of Witzelsucht is a tendency to make puns, tell inappropriate jokes or pointless stories at inappropriate times. The patient finds these utterances intensely amusing. This is often accompanied by a general disinhibition, with the patient exhibiting inappropriate or impulsive behavior.
Causes[edit]
Witzelsucht is most commonly associated with lesions of the orbitofrontal cortex. This can be due to a variety of causes, including tumors, trauma, or cerebrovascular events. It is most commonly seen in patients with right frontal lobe damage.
Diagnosis[edit]
Diagnosis of Witzelsucht is primarily clinical, based on the patient's symptoms and behavior. Neuroimaging, such as MRI or CT scan, may be used to identify any lesions in the orbitofrontal cortex.
Treatment[edit]
Treatment for Witzelsucht primarily involves addressing the underlying cause of the orbitofrontal cortex lesion. This may involve surgery, radiation therapy, or medication, depending on the cause. In some cases, psychotherapy may be beneficial to help the patient manage their behavior.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
